Andrew Mazar was Appointed as Director at Northwestern-University

Date of management change: June 15, 2009 

What Happened?

Evanston, IL-based Northwestern-University Appointed Andrew Mazar as Director

 

About the Company

Northwestern University combines innovative teaching and pioneering research in a highly collaborative environment that transcends traditional academic boundaries. It provides students and faculty exceptional opportunities for intellectual, personal, and professional growth in a setting enhanced by the richness of Chicago. Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin, and part of Minnesota. In 1853 the founders purchased a 379-acre tract of land on the shore of Lake Michigan 12 miles north of Chicago. They established a campus and developed the land near it, naming the surrounding town Evanston in honor of one of the University`s founders, John Evans. After completing its first building in 1855, Northwestern began classes that fall with two faculty members and 10 students.

 

About the Person

Andrew P. Mazar, Ph.D. Dr. Mazar is a twenty year veteran of oncology drug discovery and development efforts and is internationally recognized for his basic research work on the role of the urokinase plasminogen activator (uPA) system in tumor progression and angiogenesis. Prior to joining the Chemistry of Life Processes Institute at Northwestern University, Andrew led R&D at two start-up companies in San Diego and has been responsible for advancing numerous drug candidates from discovery through mid-stage clinical trials. In addition to his translational expertise, Andrew has also overseen strategic assessment of external science, biotechnology licensing, intellectual property management partnership and has led the due diligence process. Dr. Mazar is an Associate Editor for Recent Patent Reviews on Anti - Cancer Drug Discovery and a member of the editorial board of Clinical Cancer Research. He has served on study sections for the NIDDK, NHLBI, NIH Special Emphasis Panels, VA Oncology Merit Review, AHA and the Phillip Morris External Research Program as well as a reviewer for numerous journals and is the co-author of 98 peer reviewed publications.

 

Info Source

Press Release

 
 

Other IT executives who recently changed jobs as well: Damschroder Mark, Ord Gina, Jensen Jeff, Hart Ryan, Witten Wanda, Andrews Annette, Levine Neil, Schader Ryan, Ramos Marc, Bissett Ken, Ross Lauren

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.